TY - JOUR
T1 - Intestinal bile acid composition modulates prohormone convertase 1β (PC1/3) expression and consequent GLP-1 production in male mice
AU - Morimoto, Kohkichi
AU - Watanabe, Mitsuhiro
AU - Sugizaki, Taichi
AU - Irie, Jun Ichiro
AU - Itoh, Hiroshi
N1 - Publisher Copyright:
© Copyright 2016 by the Endocrine Society.
PY - 2016/3
Y1 - 2016/3
N2 - Besides an established medication for hypercholesterolemia, bile acid binding resins (BABRs) present antidiabetic effects. Although the mechanisms underlying these effects are still enigmatic, glucagon-like peptide-1 (GLP-1) appearstobe involved.Inadditiontoafew reported mechanisms, we propose prohormone convertase 1β (PC1β), an essential enzyme of GLP-1 production, as a potent molecule in the GLP-1 release induced by BABRs. In our study, the BABR colestimide leads to a bile acid-specific G protein-coupled receptor TGR5-dependent induction of PC1/3; gene expression. Here, we focused on the alteration of intestinal bile acid composition and consequent increase of total TGR5 agonistic activity to explain the TGR5 activation. Furthermore, we demonstrate that nuclear factor of activated T cells mediates the TGR5-triggered PC1/3 gene expression. Altogether, our data indicate that the TGR5-dependent intestinal PC1/3 gene expression supports the BABR-stimulated GLP-1 release. We also propose a combination of BABR and dipeptidyl peptidase-4 inhibitor in the context of GLP-1-based antidiabetic therapy.
AB - Besides an established medication for hypercholesterolemia, bile acid binding resins (BABRs) present antidiabetic effects. Although the mechanisms underlying these effects are still enigmatic, glucagon-like peptide-1 (GLP-1) appearstobe involved.Inadditiontoafew reported mechanisms, we propose prohormone convertase 1β (PC1β), an essential enzyme of GLP-1 production, as a potent molecule in the GLP-1 release induced by BABRs. In our study, the BABR colestimide leads to a bile acid-specific G protein-coupled receptor TGR5-dependent induction of PC1/3; gene expression. Here, we focused on the alteration of intestinal bile acid composition and consequent increase of total TGR5 agonistic activity to explain the TGR5 activation. Furthermore, we demonstrate that nuclear factor of activated T cells mediates the TGR5-triggered PC1/3 gene expression. Altogether, our data indicate that the TGR5-dependent intestinal PC1/3 gene expression supports the BABR-stimulated GLP-1 release. We also propose a combination of BABR and dipeptidyl peptidase-4 inhibitor in the context of GLP-1-based antidiabetic therapy.
UR - http://www.scopus.com/inward/record.url?scp=84960540867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960540867&partnerID=8YFLogxK
U2 - 10.1210/en.2015-1551
DO - 10.1210/en.2015-1551
M3 - Article
C2 - 26789236
AN - SCOPUS:84960540867
SN - 0013-7227
VL - 157
SP - 1071
EP - 1081
JO - Endocrinology
JF - Endocrinology
IS - 3
ER -